Abstract
Toll-like receptor 4 (TLR4) signaling may play a crucial role in the occurrence of cerebral vasospasm after subarachnoid hemorrhage (SAH). The main purpose of this study was to assess if selective blockage of TLR4 on cerebral arteries prevents cerebral vasospasm development and neurological impairments after SAH in mice. One hundred fourteen mice underwent endovascular perforation SAH or sham operation and were randomly divided into the following 6 groups: sham+vehicle, sham+LPS-RS ultrapure 8 μg, sham+LPS-RS ultrapure 40 μg, SAH+vehicle, SAH+LPS-RS ultrapure 8 μg, and SAH+LPS-RS ultrapure 40 μg. A selective TLR4 antagonist, LPS-RS ultrapure (8 or 40 μg), was administered intracerebroventricularly to mice at 30 min, and the effects were evaluated by neurobehavioral tests and India-ink angiography at 24–48 h, and Western blotting and immunohistochemistry on cerebral arteries at 24 h post-SAH. Higher but not lower dosages of LPS-RS ultrapure significantly prevented post-SAH neurological impairments and ameliorated cerebral vasospasm. SAH caused TLR4 activation and cyclooxygenase-1 (COX1) upregulation in the endothelial cells and smooth muscle cells of spastic cerebral arteries, both of which were significantly suppressed by LPS-RS ultrapure. Another selective TLR4 antagonist, IAXO-102, which has a different binding site from LPS-RS ultrapure, also showed similar protective effects to LPS-RS ultrapure. These findings suggest that TLR4 signaling is implicated in cerebral vasospasm development at least partly via COX1 upregulation, and that TLR4 antagonists have therapeutic potential as a new therapy against cerebral vasospasm.
Similar content being viewed by others
Abbreviations
- ACA:
-
Anterior cerebral artery
- ANOVA:
-
Analysis of variance
- BA:
-
Basilar artery
- COX:
-
Cyclooxygenase
- COX1:
-
Cyclooxygenase-1
- COX2:
-
Cyclooxygenase-2
- CSF:
-
Cerebrospinal fluid
- DCI:
-
Delayed cerebral ischemia
- ET:
-
Endothelin
- HE:
-
Hematoxylin and eosin
- ICA:
-
Internal carotid artery
- ICAM:
-
Intercellular adhesion molecule
- IL:
-
Interleukin
- MCA:
-
Middle cerebral artery
- MCP:
-
Monocyte chemoattractant protein
- NO:
-
Nitric oxide
- PBS:
-
Phosphate-buffered saline
- NF:
-
Nuclear factor
- SAH:
-
Subarachnoid hemorrhage
- TLR4:
-
Toll-like receptor 4
- TNF:
-
Tumor necrosis factor
References
Taki W, Sakai N, Suzuki H, Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) group (2011) Determinants of poor outcome following aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: PRESAT in Japan. World Neurosurg 76:437–445
Keyrouz S, Diringer M (2007) Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 11:220. doi:10.1186/cc5958
Suzuki H (2015) What is early brain injury? Transl Stroke Res 6:1–3
Crowley RW, Medel R, Dumont AS, Ilodigwe D, Kassell NF, Mayer SA, Ruefenacht D, Schmiedek P et al (2011) Angiographic vasospasm is strongly correlated with cerebral infarction after subarachnoid hemorrhage. Stroke 42:919–923
Fang H, Wang PF, Zhou Y, Wang YC, Yang QW (2013) Toll-like receptor 4 signaling in intracerebral hemorrhage-induced inflammation and injury. J Neuroinflammation 10:27. doi:10.1186/1742-2094-10-27
Ma C, Zhou W, Yan Z, Qu M, Bu X (2015) Toll-like receptor 4 (TLR4) is associated with cerebral vasospasm and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 55:878–884
Zhang T, Su J, Guo B, Wang K, Li X, Liang G (2015) Apigenin protects blood-brain barrier and ameliorates early brain injury by inhibiting TLR4-mediated inflammatory pathway in subarachnoid hemorrhage rats. Int Immunopharmacol 28:79–87
Zhou ML, Wu W, Ding YS, Zhang FF, Hang CH, Wang HD, Cheng HL, Yin HX et al (2007) Expression of Toll-like receptor 4 in the basilar artery after experimental subarachnoid hemorrhage in rabbits: a preliminary study. Brain Res 1173:110–116
Johnson GB, Brunn GJ, Platt JL (2003) Activation of mammalian Toll-like receptors by endogenous agonists. Crit Rev Immunol 23:15–44
Suzuki H, Kawakita F (2016) Tenascin-C in aneurysmal subarachnoid hemorrhage: deleterious or protective? Neural Regen Res 11:230–231
Fujimoto M, Suzuki H, Shiba M, Shimojo N, Imanaka-Yoshida K, Yoshida T, Kanamaru K, Matsushima S et al (2013) Tenascin-C induces prolonged constriction of cerebral arteries in rats. Neurobiol Dis 55:104–109
Lee SJ, Lee S (2002) Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy 1:181–191
Zhang T, Su J, Guo B, Zhu T, Wang K, Li X (2014) Ursolic acid alleviates early brain injury after experimental subarachnoid hemorrhage by suppressing TLR4-mediated inflammatory pathway. Int Immunopharmacol 23:585–591
Chang CZ, Wu SC, Kwan AL (2014) Glycyrrhizin attenuates Toll like receptor-2, -4 and experimental vasospasm in a rat model. J Immunol Res 2014:740549. doi:10.1155/2014/740549
Wu Y, Tang K, Huang RQ, Zhuang Z, Cheng HL, Yin HX, Shi JX (2011) Therapeutic potential of peroxisome proliferator-activated receptor γ agonist rosiglitazone in cerebral vasospasm after a rat experimental subarachnoid hemorrhage model. J Neurol Sci 305:85–91
Paschon V, Takada SH, Ikebara JM, Sousa E, Raeisossadati R, Ulrich H, Kihara AH (2016) Interplay between exosomes, microRNAs and Toll-like receptors in brain disorders. Mol Neurobiol 53:2016–2028
Hanafy KA (2013) The role of microglia and the TLR4 pathway in neuronal apoptosis and vasospasm after subarachnoid hemorrhage. J Neuroinflammation 10:83. doi:10.1186/1742-2094-10-83
Altay O, Suzuki H, Hasegawa Y, Caner B, Krafft PR, Fujii M, Tang J, Zhang JH (2012) Isoflurane attenuates blood-brain barrier disruption in ipsilateral hemisphere after subarachnoid hemorrhage in mice. Stroke 43:2513–2516
Sasaki T, Murota SI, Wakai S, Asano T, Sano K (1981) Evaluation of prostaglandin biosynthetic activity in canine basilar artery following subarachnoid injection of blood. J Neurosurg 55:771–778
Munakata A, Naraoka M, Katagai T, Shimamura N, Ohkuma H (2016) Role of cyclooxygenase-2 in relation to nitric oxide and endothelin-1 on pathogenesis of cerebral vasospasm after subarachnoid hemorrhage in rabbit. Transl Stroke Res 7:220–227
Sugawara T, Ayer R, Jadhav V, Zhang JH (2008) A new grading system evaluating bleeding scale in filament perforation subarachnoid hemorrhage rat model. J Neurosci Methods 167:327–334
Zappaterra MW, LaMantia AS, Walsh CA, Lehtinen MK (2013) Isolation of cerebrospinal fluid from rodent embryos for use with dissected cerebral cortical explants. J Vis Exp 73:e50333
Yaksh TL (1999) Spinal cerebrospinal fluid chemistry and physiology. In: Artru AA (ed) Spinal drug delivery, 1st Ed. Elsevier, Amsterdam, pp. 216–217
Suzuki H, Hasegawa Y, Chen W, Kanamaru K, Zhang JH (2010) Recombinant osteopontin in cerebral vasospasm after subarachnoid hemorrhage. Ann Neurol 68:650–660
Buchanan MM, Hutchinson M, Watkins LR, Yin H (2010) Toll-like receptor 4 in CNS pathologies. J Neurochem 114:13–27
Wu Y, Zhao XD, Zhuang Z, Xue YJ, Cheng HL, Yin HX, Shi JX (2010) Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells. Brain Res 1322:102–108
Visintin A, Halmen KA, Latz E, Monks BG, Golenbock DT (2005) Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2. J Immunol 175:6465–6472
Peri F, Piazza M, Calabrese V, Damore G, Cighetti R (2010) Exploring the LPS/TLR4 signal pathway with small molecules. Biochem Soc Trans 38:1390–1395
Titova E, Ostrowski RP, Zhang JH, Tang J (2009) Experimental models of subarachnoid hemorrhage for studies of cerebral vasospasm. Neurol Res 31:568–581
Vanhoutte PM (2011) Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension 57:526–531
Mukherjee K, Gitlin JM, Loftin CD (2012) Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype. J Cardiovasc Pharmacol 60:520–529
Shimamura N, Ohkuma H (2014) Phenotypic transformation of smooth muscle in vasospasm after aneurysmal subarachnoid hemorrhage. Transl Stroke Res 5:357–364
Flavahan NA (2007) Balancing prostanoid activity in the human vascular system. Trends Pharmacol Sci 28:106–110
Vanhoutte PM (2009) COX-1 and vascular disease. Clin Pharmacol Ther 86:212–215
Liang C-F, Liu JTC, Wang Y, Xu A, Vanhoutte PM (2013) Toll-like receptor 4 mutation protects obese mice against endothelial dysfunction by decreasing NADPH oxidase isoforms 1 and 4. Arterioscler Thromb Vasc Biol 33:777–784
Acknowledgments
We thank Ms. Chiduru Yamamoto (Department of Neurosurgery, Mie University Graduate School of Medicine) for her technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from SENSHIN Medical Research Foundation to Dr. Suzuki, and Japan Society for the Promotion of Science to Dr. Fujimoto.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was funded by a Grant-in-Aid for Scientific Research from SENSHIN Medical Research Foundation to Dr. Suzuki, and Japan Society for the Promotion of Science to Dr. Fujimoto.
Conflict of Interest
The authors declare that they have no conflict of interest.
Research Involving Animals
All procedures were approved by the Animal Ethics Review Committee of Mie University and were carried out according to the institution’s Guidelines for Animal Experiments.
Electronic supplementary material
ESM 1
(PDF 4714 kb)
Rights and permissions
About this article
Cite this article
Kawakita, F., Fujimoto, M., Liu, L. et al. Effects of Toll-Like Receptor 4 Antagonists Against Cerebral Vasospasm After Experimental Subarachnoid Hemorrhage in Mice. Mol Neurobiol 54, 6624–6633 (2017). https://doi.org/10.1007/s12035-016-0178-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-016-0178-7